THE ROYAL MELBOURNE HOSPITAL IS CALLING FOR PARTICIPANTS
Do you have Systemic or Cutaneous Mastocytosis and have Significant Symptoms?
A new trial has started at The Royal Melbourne Hospital using Omalizumab, a medication used by people with asthma
The study asks:
Can the mast cells in people with mastocytosis also be controlled by Omalizumab?
This project has been approved by the Melbourne Health Human Research Ethics Committee (Study Number: 2013.026) Participation in this study is voluntary. Any information we gain in the course of the study will be protected as confidential and anonymous.
FURTHER INFORMATION CAN BE OBTAINED FROM THE DEPARTMENT BY CONTACTING
CLINICAL TRIAL NURSE – STEWART DUNCUM ON 03 9342 3901